Cargando…
Rapamycin promotes differentiation increasing βIII-tubulin, NeuN, and NeuroD while suppressing nestin expression in glioblastoma cells
Glioblastoma cells feature mammalian target of rapamycin (mTOR) up-regulation which relates to a variety of effects such as: lower survival, higher infiltration, high stemness and radio- and chemo-resistance. Recently, it was demonstrated that mTOR may produce a gene shift leading to altered protein...
Autores principales: | Ferrucci, Michela, Biagioni, Francesca, Lenzi, Paola, Gambardella, Stefano, Ferese, Rosangela, Calierno, Maria Teresa, Falleni, Alessandra, Grimaldi, Alfonso, Frati, Alessandro, Esposito, Vincenzo, Limatola, Cristina, Fornai, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444688/ https://www.ncbi.nlm.nih.gov/pubmed/28418837 http://dx.doi.org/10.18632/oncotarget.15906 |
Ejemplares similares
-
Rapamycin Ameliorates Defects in Mitochondrial Fission and Mitophagy in Glioblastoma Cells
por: Lenzi, Paola, et al.
Publicado: (2021) -
RBFOX3/NeuN is dispensable for visual function
por: Lin, Yi-Sian, et al.
Publicado: (2018) -
Vacuolar Protein Sorting Genes in Parkinson's Disease: A Re-appraisal of Mutations Detection Rate and Neurobiology of Disease
por: Gambardella, Stefano, et al.
Publicado: (2016) -
NeuN As a Neuronal Nuclear Antigen and Neuron Differentiation Marker
por: Gusel’nikova, V. V., et al.
Publicado: (2015) -
RBFOX3/NeuN is Required for Hippocampal Circuit Balance and Function
por: Wang, Han-Ying, et al.
Publicado: (2015)